Health News 8 August 2025 - 20 August 2025

Over the past 48 hours, the life sciences world delivered a cascade of major headlines – from an experimental cancer vaccine that almost hit its mark, to a historic FDA approval of ketamine, to a disease outbreak blamed on climate change. Below we recap the most significant biotech, pharmaceutical, medical, and public health developments from August 11 and 12, 2025. Each section highlights key stories – including corporate deals, clinical trial results, regulatory moves, tech innovations, and global health alerts – with expert commentary and sources for verification.

Sources: The information above is sourced from recent press releases, regulatory announcements, and news reports between Aug 7–8, 2025, including Scripps Research eurekalert.org eurekalert.org, EurekAlert! eurekalert.org, Boston Globe kffhealthnews.org bostonglobe.com, UC Davis Health News health.ucdavis.edu health.ucdavis.edu, U.S. FDA releases fda.gov fda.gov fda.gov fda.gov, BioSpace and Reuters coverage of industry developments biospace.com reuters.com biospace.com biospace.com reuters.com reuters.com reuters.com reuters.com reuters.com, and health policy analyses from KFF Health News reuters.com reuters.com kffhealthnews.org. Each cited item is linked to its original source for further reading.